The State of Wearable Health Data in 2026: Market Trends, Challenges, and What Comes Next

The wearable health data industry in 2026 is defined by a paradox: the technology has never been more capable, the data has never been richer, and the market has never grown faster, yet the structural problems of fragmentation, interoperability, privacy and regulation remain largely unsolved. In 2026 a new one joined them: access to the data itself became less certain.

This article maps the current landscape: where the market stands, what the persistent challenges are, and where the industry is heading. It was first published in March 2026 and updated in November 2026.

How big is the wearable health data market in 2026?

The wearable health technology market is growing on every axis that matters.

Market size. The wearable fitness tracker market is projected at $70.3 billion in 2026, up from $60.0 billion in 2025, a 17.1% year-over-year growth rate [1]. The broader wearable technology market, including earwear and smart clothing, is forecast at $175 billion in 2026, on track toward $383.5 billion by 2032 [2].

Device shipments. Global wearable device shipments are expected to reach 614 million units in 2026, up from 591 million in 2025 [2]. Fitness tracker shipments specifically are projected at 192 million units [3].

Device categories. The landscape is diversifying beyond wrist-worn devices:

Smart rings are the breakout category: growing at 32.5% annually, the smart ring market is projected to reach $417 to 519 million in 2026 [3][4]. We compare the brands, prices and data access in the smart ring market in 2026, and why health data is concentrating in premium devices in the wearable market is splitting in two.

Consumer demand signals. 70% of consumers prioritize health features (ECG, blood oxygen, heart monitoring) when choosing wearables [2]. About 40% of newly launched devices in 2026 are expected to include AI-enabled functions [2]. More than 75% of respondents say they’re open to using wearable devices in the future [2]. In Andreessen Horowitz’s November 2026 survey of 500 US adults, 54% used a wearable and 83% of those checked it every day [21].

Women’s wearable tech: the fastest-growing segment

Women’s health is the wearable market’s breakout vertical. Femtech, meaning wearables built around reproductive, menstrual, hormonal and maternal health, is growing at roughly 14 to 15% annually, faster than the wearable market overall [16]. It is driven by cycle and fertility tracking, pregnancy and menopause monitoring, and a structural data gap: most health baselines and algorithms were built on male physiology, leaving women’s health systematically underserved.

It’s a large enough shift to stand on its own. We break down the women’s wearable market, its size, the capital behind it and the cycle-biomarker science that makes it work, in The FemTech Opportunity: Why Women’s Health Data Is the Biggest Gap in Digital Health.

What is a medical smartwatch, and how big is the clinical wearable market?

The fastest-growing part of the wearable market isn’t the consumer smartwatch; it’s the medical-grade device. Consumer wearables still hold the larger share, but clinical-grade wearable medical devices are the fastest-growing segment, expanding at roughly 25% annually as sensors that were once consumer novelties earn regulatory clearance for medical claims [17][18].

The dividing line is FDA clearance, and the list of cleared smartwatch-class features keeps growing [18]:

• Blood pressure: Omron’s HeartGuide became the first FDA-cleared oscillometric blood-pressure wearable, and has since gained payer coverage.
• Atrial fibrillation: Withings’ ScanWatch 2 earned clearance for AFib detection, with its data flowing into Epic and Cerner records at dozens of accountable-care organizations.
• Sleep apnea: Apple received FDA clearance for sleep-apnea detection on Apple Watch.

This is the same boundary the WHOOP warning letter drew (covered below): a “medical smartwatch” isn’t really a hardware category, it’s a regulatory one. The moment a wrist device’s output is framed as diagnosing or measuring a clinical condition, it crosses from wellness into medical-device territory, and the data it produces inherits clinical expectations for accuracy, validation and record-keeping. That makes the clinical segment the highest-value and highest-burden corner of the market at once. We trace this consumer-to-clinical crossover in Remote Patient Monitoring Is Going Consumer.

What’s new in wearable health technology?

Cuffless blood pressure monitoring

The race to deliver cuffless blood pressure from a wrist or finger is one of the defining technology stories of 2025 and 2026.

The Circular Ring 2 combines ECG and PPG sensors to measure pulse transit time, enabling 30-second blood pressure spot-checks from a ring form factor [4]. Samsung has been developing cuffless blood pressure on Galaxy Watch since 2020. Research teams have demonstrated conformal piezoelectric microsystems achieving calibration-free, continuous blood pressure tracking with accuracy comparable to cuff-based devices (mean absolute errors of 5.22 mmHg systolic, 4.57 mmHg diastolic) [5].

The technology is advancing faster than the regulatory framework can accommodate, a tension that came to a head with the WHOOP FDA warning letter in 2025 and was resolved, for that feature, when the FDA closed the letter in June 2026 (covered below). We compare the cleared and uncleared devices in cuffless blood pressure wearables.

Non-invasive glucose monitoring

Circular has announced a blood glucose trend analysis feature for the Ring 2, planned for late 2026, using PPG sensors and machine learning to analyze how light interacts with blood, providing glucose trend readings without finger pricks or continuous glucose monitors [6]. Multiple other companies are pursuing similar approaches across ring and watch form factors.

If validated, non-invasive glucose monitoring from consumer wearables would be a transformative development, potentially bringing continuous metabolic monitoring to hundreds of millions of users who would never wear a CGM patch.

Sensor fusion and multi-modal analysis

The trend across all device categories is toward combining multiple sensor types to derive higher-confidence health signals. Modern flagship devices integrate optical heart rate sensors, accelerometers, gyroscopes, barometers, skin temperature sensors, SpO2 sensors, and in some cases ECG electrodes and bioimpedance sensors.

The value isn’t in any single sensor; it’s in the algorithms that fuse multiple data streams to produce reliable health metrics. This is where AI and machine learning are making the most practical impact: not in generating health advice, but in extracting signal from noisy multi-sensor data.

Why is wearable health data so hard to integrate?

The wearable market’s growth has amplified its most persistent structural challenge: every manufacturer builds its own data silo.

The fragmentation landscape

Each wearable brand uses different data formats, schemas, APIs, authentication systems and metric definitions [7][8]:

• Garmin returns total_sleep_seconds; Oura uses sleep_duration_minutes; Apple provides HKCategoryValueSleepAnalysisAsleep
• Access works four different ways: on-device permissions for Apple HealthKit and Google Health Connect, OAuth 2.0 to clouds such as Oura, WHOOP and Withings, and partner programs such as Garmin’s that you apply to before OAuth, as we set out in the four consent models for health data
• Heart rate variability calculations differ between manufacturers: the “HRV” number from an Apple Watch, an Oura Ring and a WHOOP strap use different algorithms and time windows
• Sleep staging classification varies: what one device calls “light sleep” may overlap with another’s “core sleep”

The developer burden

For app developers, this fragmentation translates directly into engineering cost [7][8]:

• Integrating each wearable API separately takes 4 to 8 weeks of developer time per device
• Supporting 3 to 5 popular wearable brands can require up to 12 months of development
• Each integration requires ongoing maintenance as manufacturers update their APIs
• Data normalization, mapping different schemas into a unified model, is a permanent engineering challenge

2026 added a business burden on top of the engineering one. Garmin’s seven-month closure, Strava’s ban on intermediaries and the Fitbit Web API turndown each forced teams to re-plan integrations they thought were finished. Budget for access to change, not only for code to change.

Standardization efforts

FHIR (Fast Healthcare Interoperability Resources) is emerging as a potential bridge, particularly for clinical applications. A 2025 case study demonstrated that Garmin wearable data could be mapped into a FHIR-compliant format for the European Health Data Space [9]. Google has added FHIR-based medical records support to Health Connect.

However, FHIR adoption in consumer wearables remains limited. The standard was designed for clinical health data, and mapping consumer fitness metrics to FHIR resources adds complexity without clear benefits for most consumer app use cases.

The practical solution for most developers remains health data APIs that normalize data across manufacturers behind a single integration, collapsing the multi-vendor interoperability problem into the vendor’s responsibility rather than the app developer’s.

How is wearable health data regulated in 2026?

2025 and 2026 marked a pivotal period for wearable health data regulation, defined by a high-profile enforcement action, a recalibration of FDA guidance, and the enforcement action’s resolution.

The WHOOP warning letter

In July 2025, the FDA issued a warning letter to WHOOP regarding its Blood Pressure Insights (BPI) feature [10]. The FDA determined that BPI constituted a medical device being marketed without clearance because:

• It provided daily systolic and diastolic blood pressure estimations
• Marketing materials described it as offering “medical-grade health & performance insights”
• The interface used color-coding (green, yellow, orange) to indicate blood pressure ranges, implying diagnostic thresholds
• Blood pressure measurement is “inherently associated with the diagnosis of hypo- and hypertension” [10]

WHOOP argued that BPI was designed for wellness and performance insights, not diagnosis, and that the FDA was overstepping its authority [11]. The case crystallized a fundamental tension in the industry: as consumer wearable sensors become capable of measuring clinical-grade metrics, the line between “wellness” and “medical device” blurs.

On 17 June 2026 the FDA closed the warning letter after WHOOP modified the feature, including the dial boundaries that could be read as clinical classification [19]. The resolution confirmed the lesson: the measurement could stay, but the presentation had to change.

The FDA’s 2026 guidance update

In January 2026, the FDA updated two key guidance documents to clarify boundaries [12]:

Updated General Wellness Guidance: relaxed restrictions on low-risk wellness products, clarifying that devices providing general wellness claims (fitness, sleep, activity monitoring) with physiologic parameters (blood pressure, SpO2, glucose, HRV) may fall outside medical device regulation if they don’t make specific disease-related claims.

Updated Clinical Decision Support Software Guidance: provided clearer criteria for when software that processes health data crosses into medical device territory.

The net effect: clearer rules for manufacturers making general wellness claims, but continued FDA authority over features that make diagnostic or treatment claims. The boundary is in the claims, not the technology.

Medicare and remote monitoring

Payment rules moved too. Medicare’s CY 2027 Physician Fee Schedule final rule, released on 4 November 2026, requires a face-to-face initiating visit before remote patient monitoring begins from January 2027, and from 2029 pays only when the practice’s own employees do the monitoring work [20]. Consumer wearables are not billable RPM devices, but they increasingly sit around them as context between readings.

What this means for developers

For app developers integrating wearable health data:

• General wellness features (fitness tracking, sleep monitoring, activity scores, behavioral insights) remain low-risk from a regulatory perspective
• Features that imply diagnosis (blood pressure readings with clinical thresholds, arrhythmia detection, disease-specific alerts) may trigger medical device classification
• The framing matters as much as the measurement: presenting a metric as “wellness insight” vs “clinical measurement” carries different regulatory implications
• Working with pre-computed health scores and behavioral signals (rather than raw clinical metrics) generally stays within wellness territory

Is wearable health data protected by HIPAA?

Wearable health data occupies a regulatory gap that grows more concerning as devices collect more sensitive data.

The HIPAA gap

Consumer wearable data is generally not protected by HIPAA [13]. HIPAA applies to covered entities (healthcare providers, insurers, clearinghouses) and their business associates. Data collected by a fitness tracker app, even if it includes heart rate, blood pressure and sleep data, typically falls outside this framework because it’s not generated within a healthcare relationship.

This means wearable companies set their own rules for data handling, sharing and monetization, constrained primarily by their privacy policies, the FTC Act’s prohibition on deceptive practices, and emerging state-level laws.

Manufacturer privacy practices

A 2025 systematic analysis of 17 leading wearable manufacturers found significant privacy concerns [14]:

• 76% had transparency issues in their data practices
• 65% had vulnerability disclosure problems
• Google, Apple and Polar ranked lowest-risk
• Smaller manufacturers and newer market entrants showed the highest privacy risk scores

Emerging protections

Several regulatory developments are narrowing the gap:

• The FTC’s Health Breach Notification Rule now explicitly requires wearable data companies to notify users of data breaches [15]
• State-level laws like Washington’s My Health My Data Act provide additional protections for consumer health data beyond HIPAA
• The European Health Data Space (EHDS) mandates interoperability standards and governs secondary use of health data for research [15]
• The HHS Delphi program (announced March 2026) represents federal investment in biowearable technology but has raised concerns about government access to continuous health data [13]

What this means for product teams

Privacy is increasingly a competitive differentiator, not just a compliance checkbox:

• Transparent data practices build user trust and reduce churn (privacy concerns are a documented driver of health app abandonment)
• On-device processing, computing health metrics locally rather than transmitting raw data, is both a privacy feature and a technical architecture decision
• Compliance with the strictest applicable standard (HIPAA, GDPR, state laws) future-proofs against tightening regulations

What are the six trends shaping wearable health data?

1. From fitness tracking to health monitoring

The wearable industry’s center of gravity is shifting from activity tracking (steps, workouts, calories) toward continuous health monitoring (cardiovascular risk, metabolic health, mental wellbeing, respiratory function). This expands the addressable market from fitness enthusiasts to anyone managing or preventing chronic conditions, a dramatically larger population.

2. From single-device to multi-source data fusion

Users increasingly wear multiple devices (a smartwatch during the day, a ring at night, earbuds during commutes) and carry smartphones constantly. In a16z’s 2026 survey, 71.9% of wearable users said they would wear a second device if it measured something new [21]. The future belongs to systems that fuse data across all available sources, deduplicating, normalizing and synthesizing a unified health picture from whatever combination of devices a user happens to own.

3. From raw metrics to derived intelligence

Raw heart rate data or step counts are commoditized. The value is moving up the stack: from data to biomarkers, from biomarkers to health scores, from scores to behavioral insights, from insights to actionable recommendations. Each layer of abstraction makes health data more useful to product teams and more meaningful to end users. The gap is real: 55% of wearable users in the same survey said their data had never prompted a behavior change or a doctor’s visit [21], which we unpack in a16z’s State of Longevity.

4. From reactive measurement to predictive signals

Today’s wearables tell you what happened (you slept 6.5 hours, your HRV was 42ms). Tomorrow’s systems will tell you what’s likely to happen and what to do about it, using trend analysis, population comparisons and pattern detection to surface early warning signals before problems become acute.

5. From standalone to embedded

Health data is becoming a horizontal capability embedded across industries, not a vertical product category. Insurance products use it for underwriting and incentives. Retail brands use it for personalized commerce. Employers use it for wellness programs. Coaching platforms use it for adaptive programming. The wearable device is the collection point, but the value creation happens in the applications that consume the data.

6. From open APIs to permissioned access

The era of free, open wearable APIs is ending. In 2026 Garmin closed its developer program for seven months and reopened it with paid tiers and a per-user fee, Strava began charging for API access and banned intermediaries, and Google scheduled the Fitbit Web API to be turned off, with Google Fit’s APIs ending with the year. Each platform is deciding who may build on its users’ data, and on what terms.

The consequence for builders is that a wearable integration is now a business dependency as much as a technical one. Contracts, fees and approval queues belong in the plan alongside the code, and products that rely on a single direct integration carry the most risk. We cover each change in Garmin’s reopened API, Strava’s 2026 API changes and the Fitbit Web API shutdown.

What this means for builders

For product teams building health-aware applications, the state of wearable health data in 2026 presents both opportunity and complexity:

The opportunity: More users have health-generating devices than ever before. The data is richer. The use cases are expanding into new industries. Consumer willingness to share health data for value is high.

The complexity: Device fragmentation is worsening as new form factors emerge. Platform access can change within months, as Garmin, Strava and Fitbit showed in 2026. Regulatory boundaries are clarifying but still evolving. Privacy expectations are rising. Normalizing data across the growing device landscape requires infrastructure that most teams can’t justify building and maintaining in-house.

The teams that capture the opportunity while managing the complexity will be the ones who focus their engineering on the intelligence and experience layers, the parts that differentiate their products, while relying on purpose-built infrastructure for the data collection, normalization and processing layers underneath.

The wearable health data landscape has never been more promising. The challenge is no longer whether the data exists. It’s how fast you can turn it into something your users value.